文献速递心脑血管急症创伤与烧伤

抗凝患者轻度脑损伤后迟发性颅内出血的发生率与危险因素:多中心回顾性研究

Incidence and risk factors for delayed intracranial hemorrhage after mild brain injury in anticoagulated patients: a multicenter retrospective study.
PubMed 文献 · Scand J Trauma Resusc Emerg Med · 2025-02-10
一句话结论抗凝合并轻度脑损伤且首次CT阴性者迟发性颅内出血少见(DOACs 1.8%、VKAs 2.6%),均无需神经外科干预;作者认为常规复查CT可能不必要。

意大利北部三家医院急诊科2017年1月至2021年12月的多中心观察性回顾性队列研究,纳入1596例服用DOACs或VKAs、因轻度创伤性脑损伤就诊、首次CT阴性并在12-24小时后复查CT的成人患者。DOACs组869例(54%)、VKAs组727例(46%),中位年龄84岁[79-88],女性56%。迟发性颅内出血发生率DOACs组1.8%(95%CI 1.1-3.0%;14/869)、VKAs组2.6%(95%CI 1.6-4.1%;19/727),无病例需神经外科干预;头部外伤后呕吐(OR 4.8;95%CI 1.4-16.5)和观察期间出现新症状(OR 4.7;95%CI 1.2-23.7)与迟发性出血风险升高相关;30天随访2%患者因既往轻度脑损伤再次急诊就诊,两组无显著差异。作者认为常规第二次CT可能不必要,仅在高危临床危险因素或恶化征象时考虑。

要点

  • 服用DOACs或VKAs的轻度脑损伤患者首次CT阴性后,迟发性颅内出血发生率分别为1.8%(95%CI 1.1-3.0%;14/869)和2.6%(95%CI 1.6-4.1%;19/727)。
  • 全部迟发性颅内出血病例均无需神经外科干预。
  • 头部外伤后呕吐与迟发性出血风险升高相关(OR 4.8;95%CI 1.4-16.5)。
  • 观察期间出现新症状与迟发性出血风险升高相关(OR 4.7;95%CI 1.2-23.7)。
  • 30天随访2%患者因既往轻度脑损伤再次急诊就诊,两组间无显著差异。

适用人群与场景

  • 年龄≥18岁、正在服用DOACs或VKAs、因轻度创伤性脑损伤就诊于急诊科、首次头颅CT阴性并在12-24小时后接受第二次CT扫描的连续患者。
  • 研究在意大利北部三家医院的急诊科开展,时间为2017年1月至2021年12月。

红旗征与不能漏的情况

  • 头部外伤后呕吐与迟发性颅内出血风险升高相关(OR 4.8;95%CI 1.4-16.5)。
  • 观察期间出现新症状与迟发性颅内出血风险升高相关(OR 4.7;95%CI 1.2-23.7)。

研究设计与关键结果

  • 多中心、观察性、回顾性队列研究,纳入1596例抗凝患者,DOACs组869例(54%)、VKAs组727例(46%)。
  • 中位年龄84岁[79-88],女性占56%。
  • 迟发性颅内出血发生率:DOACs组1.8%(95%CI 1.1-3.0%;14/869),VKAs组2.6%(95%CI 1.6-4.1%;19/727),无病例需神经外科干预。
  • 头部外伤后呕吐与迟发性出血风险升高相关(OR 4.8;95%CI 1.4-16.5),观察期间出现新症状亦相关(OR 4.7;95%CI 1.2-23.7)。
  • 30天随访时2%患者因既往轻度脑损伤再次急诊就诊,两组间无显著差异。

证据类型、等级与局限

  • 证据类型:多中心、观察性、回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,抗凝合并轻度脑损伤患者常规第二次CT扫描可能不必要,可仅在高危临床危险因素或恶化征象时考虑。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Anticoagulated patients with mild traumatic brain injury (mTBI) and a negative cerebral CT on admission, commonly undergo a repeated CT scan after observation in the emergency department (ED) to detect delayed intracranial hemorrhage (ICH). However, the utility of this practice is controversial, with recent evidence suggesting that the risk of delayed ICH in these patients is low. This study aims to evaluate incidence, outcomes, and risk factors of delayed ICH in patients receiving direct oral anticoagulants (DOACs) or vitamin K antagonists (VKAs) presenting to the ED with mTBI.

METHODS: A multicenter, observational, retrospective cohort study was conducted in the EDs of three hospitals in Northern Italy, from January 2017 to December 2021. All consecutive adult patients on DOACs or VKAs therapy, admitted for a mTBI, who underwent a second CT scan after 12-24 h from a negative first one, were enrolled.

RESULTS: A total of 1596 anticoagulated patients were enrolled, 869 (54%) on DOACs and 727 (46%) on VKAs therapy. The median age was 84 [79-88] and 56% of patients were females. The incidence of delayed ICH was 1.8% (95% CI: 1.1-3.0%; 14/869 patients) for DOACs, and 2.6% (95% CI: 1.6-4.1%; 19/727 patients) for VKAs patients, with no cases requiring neurosurgical intervention. Vomiting after head injury and the onset of new symptoms during observation were associated with a higher risk of delayed bleeding (OR 4.8; 95% CI: 1.4-16.5, and OR 4.7; 95% CI 1.2-23.7, respectively). At a 30-day follow-up, 2% of patients had a new ED admission related to their previous mTBI, with no significant difference between the groups.

CONCLUSIONS: Delayed ICH is uncommon among anticoagulated patients with mTBI and has minimal impact on their outcome. Routine performance of a second CT scan may be unnecessary and may be considered only in presence of high-risk clinical risk factors or signs of deterioration.

来源:Scand J Trauma Resusc Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Capsoni N, Carpani G, Tarantino F, et al. Incidence and risk factors for delayed intracranial hemorrhage after mild brain injury in anticoagulated patients: a multicenter retrospective study. Scand J Trauma Resusc Emerg Med. 2025. PMID: 39930444. doi:10.1186/s13049-025-01337-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。